MedPath
HSA Approval

EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML

SIN17229P

EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML

EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML

May 2, 2025

DKSH SINGAPORE PTE. LTD.

Regulatory Information

DKSH SINGAPORE PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS

Medical Information

D11AH10

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

Eli Lilly and Company

Active Ingredients

Lebrikizumab

250 mg/2 mL

Lebrikizumab

Documents

Package Inserts

EBGLYSS Solution for Injection in Pre-filled Pen PI.pdf

Approved: May 2, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML - HSA Approval | MedPath